|
No.
|
age (y)
|
Duration
|
Location
|
Size (cm)
|
Treatment
|
Pathology
|
Follow –up
|
Outcome
|
|---|
|
12
|
53
|
NA
|
L.s
|
6 × 7
|
RO
|
WDL
|
3 yr
|
Recurrence
|
|
22
|
70
|
6 mo
|
R.s
|
13 × 7 × 3.5
|
RO
|
WDL
|
6 yr
|
Recurrence
|
|
32
|
34
|
NA
|
L.s
|
1.5 × 2.5
|
RO
|
WDL
|
4 yr
|
NRD
|
|
42
|
56
|
10 yr
|
L.s
|
8.5 × 7.5 × 4.5
|
RO+rad
|
PDL, WDL
|
18 mo
|
NRD
|
|
52
|
53
|
NA
|
L.s
|
NA
|
RO
|
DL
|
18 mo
|
NRD
|
|
62
|
71
|
2 yr
|
L.s
|
NA
|
RO
|
WDL
|
3 mo
|
NRD
|
|
75
|
59
|
5 yr
|
L.s
|
50 × 27.5 × 15 (10.9 kg)
|
RO
|
WDL
|
3 yr
|
NRD
|
|
86
|
60
|
7 mo
|
R.s; RP
|
14 × 3.8 × 3.5; 24 × 10 × 8
|
TR; RO
|
WDL (St)
|
4 yr
|
NRD
|
|
97
|
71
|
5 mo
|
L.s
|
9.5 × 5.5
|
RO
|
DL
|
4 mo
|
NRD
|
|
108
|
52
|
3 mo
|
L.s
|
0.4
|
TR
|
WDL
|
3 yr
|
NRD
|
|
1110
|
69
|
1 yr
|
L.s
|
16 × 6 × 5
|
RO+rad
|
WDL (St)
|
NA
|
NA
|
|
1211
|
53
|
6 mo
|
R.s
|
7.5 × 4.5 × 4
|
RO
|
WDL (St)
|
NA
|
NA
|
|
1312
|
76
|
1 wk
|
L.s
|
6 × 5 × 3
|
TR
|
WDML
|
NA
|
NA
|
|
1413
|
24
|
6 mo
|
R.s
|
5
|
TR
|
WDML
|
1 yr
|
NRD
|
|
1514
|
79
|
3 mo
|
L.s
|
12 × 6 (730 g)
|
RO
|
ML
|
1 yr
|
NRD
|
|
1615
|
60
|
4 yr
|
R.s
|
15 × 20 (760 g)
|
RO
|
WDML
|
NA
|
NA
|
|
1716
|
44
|
1 yr
|
L.s
|
20 × 15
|
RO
|
WDL (St)
|
1 yr
|
NRD
|
|
1817
|
60
|
6 yr
|
R.s
|
5 × 4
|
RO
|
WDL
|
3 yr
|
NRD
|
|
1918
|
75
|
18 mo
|
L.s
|
20 × 15
|
RO
|
ML
|
NA
|
NA
|
|
2018
|
54
|
NA
|
L.s
|
20 × 20
|
RO
|
PL
|
NA
|
NA
|
|
2119
|
73
|
6 mo
|
R.s
|
15 × 10 × 14
|
RO
|
WDL
|
8 yr
|
NRD
|
|
2219
|
47
|
NA
|
R.s
|
3
|
RO
|
WDL
|
20 mo
|
NRD
|
|
2320
|
73
|
1 yr
|
R.s
|
17 × 13 × 4
|
RO rad
|
DL
|
2 yr
|
NRD
|
|
2420
|
68
|
1mo
|
R.s
|
8 × 6 × 6
|
RO
|
WDL (St)
|
6 mo
|
NRD
|
|
2522.
|
73
|
NA
|
L.s; RP
|
4.1 × 3.5 × 3; 3.3 × 3.3 × 2
|
RO; TR
|
NA
|
6 mo
|
NRD
|
|
2623
|
40
|
NA
|
R.s
|
50 × 50 × 35 (42 kg)
|
TR
|
WDL (St)
|
12 mo
|
NRD
|
|
2724
|
65
|
NA
|
R.s
|
34 × 22 × 17 (5,786 g)
|
RO
|
DL
|
48 mo
|
NRD
|
|
2825
|
75
|
NA
|
NA
|
14 × 8 × 9
|
RO
|
PL
|
NA
|
NA
|
|
2926
|
47
|
6 mo
|
L.s
|
4 × 3 × 3; 4 × 2 × 2
|
RO
|
WDML; A
|
30 mo
|
NRD
|
|
3027
|
73
|
18 mo
|
L.s
|
10 × 8 × 7
|
RO
|
ML
|
NA
|
NA
|
|
3129
|
65
|
1 yr
|
R.s
|
14 × 8 × 5
|
RO
|
WDML
|
3 mo
|
NRD
|
|
3230
|
64
|
4 yr
|
L.s
|
26 × 15 × 7 (785 g)
|
RO
|
WDL
|
3 mo
|
NRD
|
|
3332
|
57
|
1.5 yr
|
L.s
|
11 × 7.5 × 5
|
RO+rad
|
DL
|
10 yr
|
NRD
|
|
3432
|
60
|
NA
|
R.s
|
3 × 1.8 × 1.5
|
RO
|
WDL (St)
|
1 yr
|
Recurrence
|
|
3533
|
57
|
1 yr
|
L.s
|
9 × 6.5
|
RO+rad
|
DL
|
NA
|
NA
|
|
3634
|
66
|
3 mo
|
R.s
|
5 × 10
|
RO
|
PDML
|
6 mo
|
Metastases
|
|
3735
|
60
|
1 yr
|
L.s
|
10 × 10 × 5
|
RO
|
WDL (St)
|
3 yr
|
Recurrence
|
|
3836
|
48
|
2 yr
|
R.s
|
NA
|
RO
|
WDL
|
3 yr
|
NRD
|
|
Our case
|
53
|
2 yr
|
L.s
|
6 × 5 × 3
|
RO
|
WDML
|
18 mo
|
NRD
|
- Abbreviations: A, angiolipoma; DL, dedifferentiated liposarcoma; L.s, left side; ML, myxoid liposarcoma; NA, not available; NRD, no recurrence of disease; PDL, poorly-differentiated liposarcoma; PDML, poorly-differentiated myxoid liposarcoma; PL, pleomorphic liposarcoma; rad, radiotherapy; R.s, right side; RO, radical orchiectomy; RP, retroperitoneum; St, sclerosing type; TR, tumor resection; WDL, well-differentiated liposarcoma; WDML, well-differentiated myxoid liposarcoma.
